EC Ophthalmology

Research Article Volume 17 Issue 2 - 2026

Epidemiological and Clinical Profile of Chronic Corneal Disorders: Insights from a Tertiary Care Hospital in Eastern India

Rakhi Kusumesh, Bibhuti Prassan Sinha, Abhishek Anand and Aniket Kumar*

Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India

*Corresponding Author: Aniket Kumar, Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
Received: December 04, 2025; Published: January 30, 2026



Purpose: This study characterized the clinical spectrum, treatment patterns, and risk factors of chronic corneal disorders in Eastern India, addressing the scarcity of region-specific data despite high disease burden.

Methods: A prospective observational study was conducted at the RIO, IGIMS, Patna, from August 2023 to April 2024. Three hundred thirty-two adult patients with confirmed chronic corneal diseases were enrolled. Demographic, clinical, and treatment data were collected using structured case report forms and analyzed using SPSS v26.0.

Results: Patients had a mean age of 44.04 ± 20.09 years with male predominance (62.7%). Corneal opacity was most prevalent (43.1%), followed by infective keratitis (39.8%). Fungal keratitis dominated infectious cases (61%), suggesting regional environmental/occupational exposure patterns. Non-infective causes (14.5%) included dry eye (5.7%) and corneal dystrophies. Severe visual impairment (BCVA < 6/60) affected 43.1% at presentation. Post-treatment, 56.3% showed ≥ 2 Snellen line improvement, with dry eye patients achieving highest recovery rates (82.4%) and fungal keratitis showing poorest response (38.1%). Artificial tears were most frequently prescribed (95.9%), followed by antibiotics (52.4%) and antifungals (25.6%). Tobacco use (29.5%) and diabetes-hypertension comorbidity (11.7%) emerged as significant risk factors (p < 0.05).

Conclusion: High regional prevalence of fungal keratitis and corneal opacity necessitates targeted interventions in Eastern India. Variable visual outcomes based on etiology and impact of modifiable risk factors highlight the need for specific prevention strategies and tailored therapeutic approaches to reduce corneal blindness burden in this population.

 Keywords: Corneal Disorders; Fungal Keratitis; Corneal Opacity; BCVA; Risk Factors; Eastern India

  1. Kate A and Basu S. “Corneal blindness in the developing world: The role of prevention strategies”. F1000Research 12 (2024): 1309.
  2. World Health Organization. “Blindness and vision impairment” (2023).
  3. Cabrera-Aguas M., et al. “Infectious keratitis: A review”. Clinical and Experimental Ophthalmology 5 (2022): 543-562.
  4. Raj N., et al. “Population-based study on the prevalence, clinical characteristics and vision-related quality of life in patients with corneal opacity resulting from infectious keratitis: results from the Corneal Opacity Rural Epidemiological study”. British Journal of Ophthalmology 4 (2023): 476-482.
  5. Narayanan S., et al. “Dry eye disease and microbial keratitis: is there a connection?”. Ocular Surface 2 (2013): 75-92.
  6. Gupta N., et al. “Burden of corneal blindness in India”. Indian Journal of Community Medicine 4 (2013): 198-206.
  7. Rautaraya B., et al. “Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India”. BMC Ophthalmology 11 (2011): 39.
  8. Tawde Y., et al. “Clinical and mycological profile of fungal keratitis from North and North-East India”. Indian Journal of Ophthalmology 6 (2022): 1990-1996.
  9. Bharathi MJ., et al. “Microbial keratitis in South India: influence of risk factors, climate, and geographical variation”. Ophthalmic Epidemiology 2 (2007): 61-69.
  10. Lin CC., et al. “Seasonal trends of microbial keratitis in South India”. Cornea10 (2012): 1123-1127.
  11. Castano G., et al. “Fungal keratitis”. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2024).
  12. Roth J., et al. “Characterization of infectious bacterial keratitis in Östergötland County, Sweden: a 10-year retrospective study”. Journal of Ophthalmic Inflammation and Infection 1 (2024): 49.
  13. Hatami H., et al. “Contact lens associated bacterial keratitis: common organisms, antibiotic therapy, and global resistance trends: a systematic review”. Frontiers in Ophthalmology (Lausanne) 1 (2021): 759271.
  14. Tan SZ., et al. “Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital”. Eye (London)8 (2017): 1229-1236.
  15. Ting DSJ., et al. “12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study”. British Journal of Ophthalmology 3 (2021): 328-333.
  16. Asbell PA., et al. “Antibiotic resistance among ocular pathogens in the united states: five-year results from the antibiotic resistance monitoring in ocular microorganisms (ARMOR) surveillance study”. JAMA Ophthalmology12 (2015): 1445-1454.
  17. Ghosh AK., et al. “Fungal keratitis in north India: Spectrum of agents, risk factors and treatment”. Mycopathologia11-12 (2016): 843-850.
  18. Satpathy G., et al. “Spectrum of mycotic keratitis in north India: Sixteen years study from a tertiary care ophthalmic centre”. Journal of Infection and Public Health 3 (2019): 367-371.
  19. Aberame AR., et al. “Assessment of prevalence of dry eye among medical students using ocular surface disease index questionnaire - Is COVID-19 to be really blamed?”. Indian Journal of Ophthalmology 4 (2023): 1450-1453.
  20. Shah R., et al. “Bridging the gender gap in eye health by training allied ophthalmic personnel”. Community Eye Health Journal 126 (2025): 18.
  21. National Programme for Control of Blindness & Visual Impairment (NPCBVI). National Blindness and Visual Impairment Survey, India 2015-2019. Ministry of Health and Family Welfare, Government of India (2019).
  22. Kulkarni A and Banait S. “Through the smoke: An in-depth review on cigarette smoking and its impact on ocular health”. Cureus 10 (2023): e47779.
  23. Priyadarsini S., et al. “Diabetic keratopathy: Insights and challenges”. Survey of Ophthalmology 5 (2020): 513-529.
  24. Mukhija R., et al. “Population-based assessment of visual impairment and pattern of corneal disease: results from the CORE (Corneal Opacity Rural Epidemiological) study”. British Journal of Ophthalmology 7 (2020): 994-998.
  25. Basak SK. “Data gap: Transplantable corneal blindness, current transplantation, and eye banking in India”. Indian Journal of Ophthalmology 9 (2023): 3125-3127.
  26. Liu R., et al. “A practical model for effective eye care delivery in Southeast Asian rural communities: A proposal built based on experts' recommendations”. Indian Journal of Ophthalmology 3 (2024): S473-S481.
  27. Tidke SC and Tidake P. “A review of corneal blindness: Causes and management”. Cureus 10 (2022): e30097.
  28. Chaurasia SB., et al. “Exploring relationship between literacy rate and lens induced glaucoma in a tertiary eye hospital in central India”. Research Journal of Medical Sciences 2 (2025): 132-136.
  29. Devi B and Kurmi S. “Etiological study of corneal blindness”. IOSR Journal of Nursing and Health Science 3,VI (2017): 66-71.

Aniket Kumar., et al. “Epidemiological and Clinical Profile of Chronic Corneal Disorders: Insights from a Tertiary Care Hospital in Eastern India”. EC Ophthalmology  17.2 (2026): 01-10.